133 related articles for article (PubMed ID: 3936564)
21. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder.
Fukui I; Sekine H; Kihara K; Yamada T; Takeuchi S; Yokokawa M; Kawai T; Hosoda K; Ohwada F; Suzuki S
J Urol; 1989 Mar; 141(3):531-4. PubMed ID: 2493099
[TBL] [Abstract][Full Text] [Related]
22. Intravesical mitomycin C for carcinoma in situ of the urinary bladder.
Hellsten S; Månsson W; Henrikson H; Idwall I; Lindholm K; Mikulowski P; Mårtensson S; Oldbring J
Scand J Urol Nephrol; 1990; 24(1):35-8. PubMed ID: 2108491
[TBL] [Abstract][Full Text] [Related]
23. DNA/RNA ratio in bladder cancer: a factor indicating the recurrence rate?
Hadjissotiriou GG; Green DK; McIntyre MA; Hargreave TB; Chisholm GD
Br J Urol; 1985 Dec; 57(6):668-75. PubMed ID: 2417650
[TBL] [Abstract][Full Text] [Related]
24. A randomized prospective study of intravesical prophylaxis in non-musle invasive bladder cancer at intermediate risk of recurrence: mitomycin chemotherapy vs BCG immunotherapy.
Mangiarotti B; Trinchieri A; Del Nero A; Montanari E
Arch Ital Urol Androl; 2008 Dec; 80(4):167-71. PubMed ID: 19235434
[TBL] [Abstract][Full Text] [Related]
25. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
[TBL] [Abstract][Full Text] [Related]
26. Topical mitomycin C therapy for carcinoma of the bladder.
Stricker PD; Grant AB; Hosken BM; Taylor JS
J Urol; 1987 Nov; 138(5):1164-6. PubMed ID: 3118056
[TBL] [Abstract][Full Text] [Related]
27. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
Fourcade RO; Giuliano F
Ann Urol (Paris); 1988; 22(6):404-6. PubMed ID: 3146942
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy for carcinoma in situ of the bladder.
Jenkins BJ; England HR; Fowler CG; Tiptaft RC; Badenoch DF; Paris AM; Oliver RT; Blandy JP
Br J Urol; 1988 Apr; 61(4):326-9. PubMed ID: 3133011
[TBL] [Abstract][Full Text] [Related]
29. Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
Smith G; Elton RA; Chisholm GD; Newsam JE; Hargreave TB
Br J Urol; 1986 Dec; 58(6):659-63. PubMed ID: 3099881
[TBL] [Abstract][Full Text] [Related]
30. Severely contracted bladder following intravesical mitomycin C therapy.
Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
[TBL] [Abstract][Full Text] [Related]
31. Mitomycin C for the treatment of bladder cancer.
Volpe A; Racioppi M; D'Agostino D; Cappa E; Filianoti A; Bassi PF
Minerva Urol Nefrol; 2010 Jun; 62(2):133-44. PubMed ID: 20562793
[TBL] [Abstract][Full Text] [Related]
32. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
33. [Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].
Liberti M; Tenaglia R; De Berardinis E; Gentile V
Minerva Med; 1984 Feb; 75(8):391-4. PubMed ID: 6424059
[TBL] [Abstract][Full Text] [Related]
34. Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guérin instillation therapy of patients with carcinoma in situ of the bladder: a subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up.
Järvinen R; Kaasinen E; Rintala E; Group TF
Scand J Urol Nephrol; 2012 Dec; 46(6):411-7. PubMed ID: 22746387
[TBL] [Abstract][Full Text] [Related]
35. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Soloway MS; Jordan AM; Murphy WM
Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
[TBL] [Abstract][Full Text] [Related]
36. Mitomycin C therapy in superficial bladder cancer.
Denis L; Keuppens F; Hendrickx G
Prog Clin Biol Res; 1985; 185B():113-22. PubMed ID: 3929269
[No Abstract] [Full Text] [Related]
37. Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
Schwarzman MI; Johanson KE; Surya B; Brown J
Urology; 1988 Oct; 32(4):335-8. PubMed ID: 3140465
[TBL] [Abstract][Full Text] [Related]
38. Intravesical mitomycin C and superficial bladder tumors.
Biserte J; Rigot JM; Mauroy B; Mazeman E
Prog Clin Biol Res; 1989; 303():411-5. PubMed ID: 2506555
[No Abstract] [Full Text] [Related]
39. Management of superficial bladder cancer in a community setting.
Haas JA
Urology; 1985 Oct; 26(4 Suppl):51-4. PubMed ID: 3931328
[TBL] [Abstract][Full Text] [Related]
40. Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors.
Wajsman Z; Dhafir RA; Pfeffer M; MacDonald S; Block A; Dragone N; Pontes JE
J Urol; 1984 Jul; 132(1):30-3. PubMed ID: 6427484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]